ERYTHROMYCIN ETHYLSUCCINATE tablet Amerika Serikat - Inggris - NLM (National Library of Medicine)

erythromycin ethylsuccinate tablet

physicians total care, inc. - erythromycin ethylsuccinate (unii: 1014ksj86f) (erythromycin - unii:63937kv33d) - erythromycin ethylsuccinate 400 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin ethylsuccinate tablets and other antibacterial drugs, erythromycin ethylsuccinate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. erythromycin ethylsuccinate tablets are indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below: upper respiratory tract infections of mild to moderate degree caused by streptococcus pyogenes , streptococcus pneumoniae , or haemophilus influenzae (when used concomitantly with adequate doses of sulfonamides, since many strains of h. influenzae are not susce

Erythromycin 250mg gastro-resistant tablets Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

erythromycin 250mg gastro-resistant tablets

alliance healthcare (distribution) ltd - erythromycin - gastro-resistant tablet - 250mg